Antilymphocyte Antibodies in Systemic Lupus Erythematosus: Association with Disease Activity and Lymphopenia

Table 1

Demographic, clinical and laboratory features of SLE patients.

Characteristics
Female, n (%)	122 (93.8)
Age, mean ± SD years	33.3±12.4
Disease duration, median (interquartile range)	2 (0.8–5)
SLEDAI, mean ± SD	9.8±5.8
Clinical features, n (%)
Lupus nephritis	64 (49.2)
NPSLE	13 (10)
Arthralgia	45 (34.6)
Serositis	15 (11.5)
Anti-dsDNA positive, n (%)	50 (38.5)
ALA, n (%)	55 (42.3)